Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases

Retina. 2003 Dec;23(6):764-70. doi: 10.1097/00006982-200312000-00003.

Abstract

Purpose: To study the advantages and complications of triamcinolone acetonide (TA)-assisted pars plana vitrectomy (PPV) for various retinal diseases.

Methods: This report is an interventional case series and nonrandomized study. One hundred seventy-seven eyes from 158 patients underwent PPV with or without TA. Group TA(+) consisted of 94 eyes and group TA(-) consisted of 83 eyes. The improvement in vision and postoperative complications were prospectively studied.

Results: Sixty-two percent of the eyes in group TA(+) and 49% of the eyes in group TA(-) had improved vision after surgery (P = 0.34). Twelve eyes in group TA(+) and 12 eyes in group TA(-) had an intraocular pressure higher than 21 mmHg after the operation, with no statistically significant difference (P = 0.63). Four eyes with proliferative diabetic retinopathy in group TA(+) and five eyes with proliferative diabetic retinopathy in group TA(-) needed an additional filtering surgery. Group TA(+) (five eyes) had a lower incidence (P = 0.041) of reoperation caused by preretinal fibrous membrane formation than group TA(-) (13 eyes). No apparent corneal disorder or infectious signs were found in any eyes.

Conclusions: Triamcinolone acetonide-assisted PPV appears to be potentially useful to reduce the incidence of reoperation owing to preretinal fibrosis with no serious complications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control
  • Reoperation
  • Retinal Diseases / drug therapy*
  • Retinal Diseases / surgery*
  • Triamcinolone Acetonide / therapeutic use*
  • Visual Acuity
  • Vitrectomy / methods*

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide